SK

Sneha Kommineni

Active Director Designated Partner DIN 11179809
DIN 11179809 First appointment Jul 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sneha Kommineni

Data last updated:

Sneha Kommineni is a Designated Partner at Spashta Healthcare Llp (since 2025).

DIN 11179809
Primary Designation Designated Partner
First Appointment 02 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Jul 20252025Active

Board colleagues of Sneha Kommineni

NameDINCompanyDesignation
Keerthana Ravipati Krishna11179811Spashta Healthcare LlpDesignated Partner
Praneeth Suryadevara11179810Spashta Healthcare LlpDesignated Partner
Suryadevara Varun11179808Spashta Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Spashta Healthcare Llp
Premium access

Shareholding and investment profile for Sneha Kommineni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sneha Kommineni

Sneha Kommineni currently holds 1 directorship: Spashta Healthcare Llp (Designated Partner, since 02 Jul 2025).

Sneha Kommineni was first appointed on 02 Jul 2025 as Designated Partner at Spashta Healthcare Llp.

The current boards of Sneha Kommineni's companies include Keerthana Ravipati Krishna (Spashta Healthcare Llp), Praneeth Suryadevara (Spashta Healthcare Llp), Suryadevara Varun (Spashta Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available